182 related articles for article (PubMed ID: 37909856)
1. Co-expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer.
Zhang Y; Liu Z; Li L; Zeng D; Sun H; Wu J; Zhou R; Liao W
J Cell Mol Med; 2023 Dec; 27(24):4181-4194. PubMed ID: 37909856
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of co-expression pattern of solute carrier transporters reveals molecular subtypes associated with tumor microenvironment hallmarks and clinical outcomes in colon cancer.
Zhou R; Li L; Zhang Y; Liu Z; Wu J; Zeng D; Sun H; Liao W
Heliyon; 2024 Jan; 10(1):e22775. PubMed ID: 38163210
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.
Chen DY; Zhang YY; Nie HH; Wang HZ; Qiu PS; Wang F; Peng YN; Xu F; Zhao Q; Zhang M
Sci Rep; 2024 Feb; 14(1):4459. PubMed ID: 38396064
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer.
Ma M; Li J; Zeng Z; Zheng Z; Kang W
Front Immunol; 2023; 14():1096488. PubMed ID: 36936957
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Shimakata T; Kamoshida S; Kawamura J; Ogane N; Kameda Y; Yanagita E; Itoh T; Takeda R; Naka A; Sakamaki K; Hayashi Y; Kuwao S
Histopathology; 2016 Nov; 69(5):812-821. PubMed ID: 27245475
[TBL] [Abstract][Full Text] [Related]
7. Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures.
Han X; Lu H; Tang X; Zhao Y; Liu H
Immun Inflamm Dis; 2022 Jan; 10(1):43-59. PubMed ID: 34582114
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma.
Yu T; Yu SK; Lu KH
Pathol Oncol Res; 2022; 28():1610610. PubMed ID: 36313898
[No Abstract] [Full Text] [Related]
9. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
10. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
Schaller L; Lauschke VM
Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
[TBL] [Abstract][Full Text] [Related]
11. Development of cancer-associated fibroblasts subtype and prognostic model in gastric cancer and the landscape of tumor microenvironment.
Zhang C; Sun D; Li C; Liu Y; Zhou Y; Zhang J
Int J Biochem Cell Biol; 2022 Nov; 152():106309. PubMed ID: 36174922
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and immune-related gene signatures: Predictive stratification and prognostic implications in gastric cancer.
Shao J; Zhang W; Li Y; Tang Y; Fan L
J Gene Med; 2024 Jan; 26(1):e3635. PubMed ID: 37984993
[TBL] [Abstract][Full Text] [Related]
13. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature.
Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X
BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046
[TBL] [Abstract][Full Text] [Related]
14. A novel scoring model based on RNA modification "writers" can predict the prognosis and guide immunotherapy in gastric cancer.
Li X; Zhou Y; Jiang Q; Huang J; Liu Z; Li Y; Guo G
Funct Integr Genomics; 2023 May; 23(2):162. PubMed ID: 37188931
[TBL] [Abstract][Full Text] [Related]
15. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer.
Zhang H; Wang H; Ye L; Bao S; Zhang R; Che J; Luo W; Yu C; Wang W
BMC Cancer; 2023 May; 23(1):454. PubMed ID: 37202737
[TBL] [Abstract][Full Text] [Related]
17. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications.
Zhou YJ; Zhu GQ; Lu XF; Zheng KI; Wang QW; Chen JN; Zhang QW; Yan FR; Li XB
Cancer Immunol Immunother; 2020 Jun; 69(6):1057-1069. PubMed ID: 32100076
[TBL] [Abstract][Full Text] [Related]
19. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
20. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
Liu ZY; Xin L
Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]